E8(R1) General Considerations for Clinical Studies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 8, 2022
April 8, 2022
c5e52286-b058-4b0f-b1f2-e589be1aaf84
Related Documents
Homeopathic Drug Products Guidance for FDA Staff and Industry
Guidance DocumentDecember 7, 2022Center for Drug Evaluation and Research
Multiple Endpoints in Clinical Trials: Guidance for Industry
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Population Pharmacokinetics: Guidance for Industry
Guidance DocumentFebruary 3, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.